Result: Measurable residual disease monitoring in AML with FLT3-ITD treated with intensive chemotherapy plus midostaurina

*Title*:

*Author/editor-in-chief*:

*Publication*:

Freiburg : Universität, 2024

*Physical description scale*:

1 Online-Ressource

*Format*:

*eBook*

*Language*:

*eng*

*Notes*:

Blood advances. - 8, 23 (2024) , 6067-6080, ISSN: 2473-9537

*DOI*:

10.1182/bloodadvances.2024013758

*Result*: Measurable residual disease monitoring in AML with FLT3-ITD treated with intensive chemotherapy plus midostaurina